首页> 外国专利> TREATMENT OF ALZHEIMER'S DISEASE LOSS OF COGNITION MEMORY LOSS AND DEMENTIA WITH SEX STEROID PRECURSORS IN COMBINATION WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS

TREATMENT OF ALZHEIMER'S DISEASE LOSS OF COGNITION MEMORY LOSS AND DEMENTIA WITH SEX STEROID PRECURSORS IN COMBINATION WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS

机译:雌激素受体前体联合选择性雌激素受体调节剂联合治疗老年痴呆患者的认知记忆力减退和痴呆

摘要

In a sensitive warm-blooded animal, it reduces the risk of developing breast cancer, uterine cancer or endometrial cancer while alleviating or eliminating the occurrence of facial flushing, vasomotor symptoms and hyperemia, and also reduces osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, As a novel method having an advantageous effect by inhibiting development of insulin resistance, type 2 diabetes, muscle mass loss, obesity, Alzheimer's disease, cognitive loss, amnesia or vaginal dryness, sex steroid precursors, especially dihydroepiandrosterone ) And an anti-estrogen or selective estrogen receptor modulator, especially a compound having the general formula: Pharmaceutical compositions and useful kit (s) for delivery of the active ingredient (s) are also disclosed by the present invention.
机译:在敏感的温血动物中,它降低了罹患乳腺癌,子宫癌或子宫内膜癌的风险,同时减轻或消除了面部潮红,血管舒缩症状和充血的发生,还减少了骨质疏松症,高胆固醇血症,高脂血症,动脉粥样硬化。通过抑制胰岛素抵抗,2型糖尿病,肌肉质量下降,肥胖,阿尔茨海默氏病,认知丧失,健忘症或阴道干燥,性类固醇前体,尤其是二氢表雄甾酮)和抗雌激素或选择性雌激素受体而产生有益效果的新方法调节剂,尤其是具有以下通式的化合物:本发明还公开了用于递送活性成分的药物组合物和有用的试剂盒。

著录项

  • 公开/公告号KR20170078879A

    专利类型

  • 公开/公告日2017-07-07

    原文格式PDF

  • 申请/专利权人 앙도르쉐르슈 인코포레이티드;

    申请/专利号KR20177017880

  • 发明设计人 라브리에 페르난드;

    申请日2010-06-16

  • 分类号A61K31/568;A61K31/085;A61K31/453;A61K9;A61K9/20;

  • 国家 KR

  • 入库时间 2022-08-21 13:27:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号